logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Chaoju Ophthalmology (02219.HK) purchased 120,000 shares for HK$326,900 on December 18th.

date
19/12/2025
According to the Securities Times APP, Chaoju Ophthalmology (02219.HK) announced that on December 18, 2025, the company spent HK$326,900 to repurchase 120,000 shares.
Latest
1 m ago
Haruhiko Kuroda, Governor of the Bank of Japan: If possible, we plan to revise the estimated value of the neutral interest rate.
1 m ago
Fangte Investment Development Company increased its capital to about 3.2 billion, an increase of 427%.
1 m ago
Bank of Japan Governor Kuroda Haruhiko: We released our estimate of the neutral interest rate after taking action from overseas central banks.
2 m ago
Daiwa: Upgrades China Construction Bank (00939.HK) target price to HK$9.9, rating "Buy"
2 m ago
Bank of Japan Governor Kuroda Haruhiko: The concept of neutral interest rates is very important for monetary policy.
See all latestmore
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.